Keeping Track: Shutdown Edition

The latest drug development news and highlights from our US FDA Performance Tracker.

Keeping Track Feature image

While the United States government shut down lasted only one business day, review and approval events in the biopharma world seem to have experience a more extended lapse. Yes, it was a slow week, but there was still enough news that it needs to be presented in brief:

The US FDA gave its blessing to Advanced Accelerator Applications SA's Lutathera (lutetium Lu 177 dotatate), marking the agency's...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Product Reviews

More from Pink Sheet